Skip to Main content Skip to Navigation
Journal articles

A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer

Abstract : Triple negative breast cancers (TNBC) remain a major medical challenge due to poor prognosis and limited treatment options. Mesothelin is a glycosyl-phosphatidyl inositol-linked membrane protein with restricted normal expression and high level expression in a large proportion of TNBC, thus qualifying as an attractive target. Its overexpression in breast tumors has been recently correlated with a decreased disease-free survival and an increase of distant metastases. The objective of the study was to investigate the relevance of a bispecific antibody-based immunotherapy approach through mesothelin targeting and CD16 engagement using a Fab-like bispecific format (MesobsFab). Using two TNBC cell lines with different level of surface mesothelin and epithelial/mesenchymal phenotypes, we showed that, in vitro, MesobsFab promotes the recruitment and penetration of NK cells into tumor spheroids, induces potent dose-dependent cell-mediated cytotoxicity of mesothelin-positive tumor cells, cytokine secretion, and decreases cell invasiveness. MesobsFab was able to induce cytotoxicity in resting human peripheral blood mononuclear cells (PBMC), mainly through its NK cells-mediated antibody dependent cell cytotoxicity (ADCC) activity. In vivo, the anti-tumor effect of MesobsFab depends upon a threshold of MSLN density on target cells. Collectively our data support mesothelin as a relevant therapeutic target for the subset of TNBC that overexpresses mesothelin characterized by a low overall and disease-free survival as well as the potential of MesobsFab as antibody-based immunotherapeutics.
Document type :
Journal articles
Complete list of metadata

Cited literature [48 references]  Display  Hide  Download
Contributor : Brigitte Kerfelec Connect in order to contact the contributor
Submitted on : Tuesday, March 31, 2020 - 11:19:34 AM
Last modification on : Monday, January 17, 2022 - 1:23:41 PM


Publication funded by an institution


Distributed under a Creative Commons Attribution 4.0 International License




Joanie del Bano, Rémy Florès-Florès, Emmanuelle Josselin, Armelle Goubard, Laëtitia Ganier, et al.. A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer. Frontiers in Immunology, Frontiers, 2019, 10, pp.1593. ⟨10.3389/fimmu.2019.01593⟩. ⟨hal-02297816⟩



Record views


Files downloads